Clinical Trial Update: Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn [Phase 4]

View source ↗

Summary

Phase 4 trial update for rasagiline (AzileCt) in cognitive-impairment related depression associated with Parkinson's disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Symptoms
• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: Lundbeck Italia S.p.A. | Conditions: Depressive Symptoms, Parkinson's Disease | Phase 4 | Status: COMPLETED